Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-13

FDA Approved: PHENDIMETRAZINE TARTRATE — Supplemental Application (Acertis Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for phendimetrazine tartrate from Acertis Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • phendimetrazine tartrate (phendimetrazine tartrate)

Snippet

SUPPL AP for PHENDIMETRAZINE TARTRATE (PHENDIMETRAZINE TARTRATE)